Want to see COYA full AI Analyst Report?
Coya Therapeutics, Inc. (COYA) Income Statement
Coya Therapeutics, Inc. Income Statement
Last quarter (Q2 2026), Coya Therapeutics, Inc.'s total revenue was $243.75K, an increase of 48.97% from the same quarter last year. In Q2, Coya Therapeutics, Inc.'s net income was $-6.64M. See Coya Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 7.95M | $ 3.55M | $ 6.00M | $ 0.00 | $ 0.00 | |
| $ 7.92M | $ -8.31M | $ 500.68K | $ -4.41M | $ 0.00 | |
| $ 28.18M | $ 8.94M | $ 8.40M | $ 5.40M | $ 4.87M | |
| Depreciation and Amortization | $ 27.36K | $ 27.36K | $ 27.36K | $ 27.36K | $ 16.13K |
| $ -21.20M | $ -17.20M | $ -7.33M | $ -9.26M | $ -4.88M | |
| $ -20.27M | $ -17.25M | $ -7.90M | $ -9.81M | $ -4.87M | |
| $ -957.39K | $ 1.65M | $ 639.37K | $ -2.43M | $ -21.48K | |
| $ -21.22M | $ -15.60M | $ -7.26M | $ -12.24M | $ -4.89M | |
| $ -21.23M | $ -14.88M | $ -7.99M | $ -12.24M | $ -4.89M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.27 | $ -0.98 | $ -0.79 | $ -1.23 | $ -0.74 |
| Diluted EPS | $ -1.27 | $ -0.98 | $ -0.79 | $ -1.23 | $ -0.74 |
| Weighted Average Shares Outstanding | 16.73M | 15.24M | 10.16M | 9.95M | 6.60M |
| Weighted Average Shares Outstanding (Diluted) | 16.73M | 15.24M | 10.16M | 9.95M | 6.60M |
Currency in USD
